On June 24, 2025, Dr. Harald Schwartz, a member of the Bavarian State Parliament for the CSU representing the district Amberg-Sulzbach, visited the LIT to discuss the institute’s latest research advancements and engage with the researchers.
Prof. Philipp Beckhove, Scientific Director of the Leibniz-Institute for Immunotherapy (LIT), was a guest on the podcast “Wirkstoffradio” and talked to the host Bernd Rupp about the cutting-edge research at the LIT (in German).
A passionate group of young scientists—many affiliated with the Leibniz Institute for Immunotherapy (LIT)—successfully brought the Pint of Science festival back to Regensburg in 2025, continuing a local tradition that they began in 2022.
“Book a Scientist” is a conversation format in which interested parties can “book” 25-minute one-on-one conversations with Leibniz scientists on fixed topics according to the speed dating principle.
Over 30 interested citizens of Regensburg, along with members of the CSU parliamentary group and Mayor Dr. Astrid Freudenstein, visited the Leibniz Institute for Immunotherapy on Tuesday, March 25.
LIT scientists Dr. Astrid Holzinger, Dr. Markus Barden and Prof. Hinrich Abken give an overview on CARs, TRUCKS and the next generation of T cell therapy in the journal JATROS Hämatologie & Onkologie.
Dr. Caio Silveira, postdoctoral scientist in the Research Division ‘Functional Immune Cell Modulation’, participated in a new campaign by the Federal Ministry of Education and Research (BMBF).
Prof. Philipp Beckhove, Scientific Director of the LIT, was guest in the podcast “Tonspur Wissen” by Leibniz Association and Rheinische Post. He talked with journalist Ursula Weidenfeld about new developments in fighting cancer with immunotherapy (in German).
Peter Aumer and Katrin Staffler, members of the German Bundestag, visited the LIT on January 24, 2024.
The Scientific Director of the Leibniz Institute for Immunotherapy (LIT), Prof. Philipp Beckhove, visited the German Bundestag. The attending deputies were impressed by the excellent research conducted at LIT. Subsequently, possibilities were discussed to enhance the international competitiveness of biomedical research in Germany.
